1.Khera AV, Kathiresan S: Genetics of coronary artery disease: discovery, biology and clinical translation. Nature reviews Genetics.2017; 18(6):331–344.
2.Singh A, Grossman SA: Acute Coronary Syndrome. In: StatPearls. edn. Treasure Island (FL); 2019.
3.Pelletier R, Humphries KH, Shimony A, Bacon SL, Lavoie KL, Rabi D et al: Sex-related differences in access to care among patients with premature acute coronary syndrome. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne.2014; 186(7):497–504.
4.Janion-Sadowska A, Sielski J, Gierlotka M, Nowalany-Kozielska E, Janion M, Polonski L: Gender-related differences in clinical course, therapeutic approach and prognosis in patients with non-ST segment elevation myocardial infarction. Kardiologia polska.2011; 69(8):784–792.
5.Pelletier R, Choi J, Winters N, Eisenberg MJ, Bacon SL, Cox J et al: Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome. The Canadian journal of cardiology.2016; 32(12):1447–1453.
6.Behera J, Bala J, Nuru M, Tyagi SC, Tyagi N: Homocysteine as a Pathological Biomarker for Bone Disease. Journal of cellular physiology.2017; 232(10):2704–2709.
7.Oudi ME, Aouni Z, Mazigh C, Khochkar R, Gazoueni E, Haouela H et al: Homocysteine and markers of inflammation in acute coronary syndrome. Experimental and clinical cardiology.2010; 15(2):e25–28.
8.Saadeddin SM, Habbab MA, Ferns GA: Markers of inflammation and coronary artery disease. Medical science monitor: international medical journal of experimental and clinical research.2002; 8(1):RA5–12.
9.Kawashiri M, Kajinami K, Nohara A, Yagi K, Inazu A, Koizumi J et al: Plasma homocysteine level and development of coronary artery disease. Coronary artery disease.1999; 10(7):443–447.
10.Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mahonen M, Ngu Blackett K et al: World Health Organization definition of myocardial infarction: 2008–09 revision. International journal of epidemiology.2011; 40(1):139–146.
11.Kim JM, Stewart R, Lee YS, Lee HJ, Kim MC, Kim JW et al: Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial. Jama.2018; 320(4):350–358.
12.Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al: Third universal definition of myocardial infarction. European heart journal.2012; 33(20):2551–2567.
13.Zhang Z, Fang J, Gillespie C, Wang G, Hong Y, Yoon PW: Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. The American journal of cardiology.2012; 109(8):1097–1103.
14.Izadnegahdar M, Singer J, Lee MK, Gao M, Thompson CR, Kopec J et al: Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years. Journal of women’s health.2014; 23(1):10–17.
15.Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J: Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Archives of internal medicine.2009; 169(19):1767–1774.
16.Sreckovic B, Sreckovic VD, Soldatovic I, Colak E, Sumarac-Dumanovic M, Janeski H et al: Homocysteine is a marker for metabolic syndrome and atherosclerosis. Diabetes & metabolic syndrome.2017; 11(3):179–182.
17.Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R et al: Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America.1994; 91(14):6369–6373.
18.Harpel PC, Chang VT, Borth W: Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proceedings of the National Academy of Sciences of the United States of America.1992; 89(21):10193–10197.
19.Dudman NP: An alternative view of homocysteine. Lancet.1999; 354(9195):2072–2074.
20.Leng YP, Ma YS, Li XG, Chen RF, Zeng PY, Li XH et al: l-Homocysteine-induced cathepsin V mediates the vascular endothelial inflammation in hyperhomocysteinaemia. British journal of pharmacology.2018; 175(8):1157–1172.
21.Saperstein DS, Barohn RJ: Peripheral Neuropathy Due to Cobalamin Deficiency. Current treatment options in neurology.2002; 4(3):197–201.
22.Leishear K, Boudreau RM, Studenski SA, Ferrucci L, Rosano C, de Rekeneire N et al: Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults. Journal of the American Geriatrics Society.2012; 60(6):1057–1063.
23.Vidoni ML, Pettee Gabriel K, Luo ST, Simonsick EM, Day RS: Vitamin B12 and Homocysteine Associations with Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging. The journal of nutrition, health & aging.2017; 21(10):1321–1328.
24.Strotmeyer ES, de Rekeneire N, Schwartz AV, Faulkner KA, Resnick HE, Goodpaster BH et al: The relationship of reduced peripheral nerve function and diabetes with physical performance in older white and black adults: the Health, Aging, and Body Composition (Health ABC) study. Diabetes care.2008; 31(9):1767–1772.
25.Virdis A, Ghiadoni L, Salvetti G, Versari D, Taddei S, Salvett A: Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension? Journal of nephrology.2002; 15(4):414–421.
26.Cibickova L, Karasek D: [Uric acid as a risk factor for cardiovascular diseases]. Vnitrni lekarstvi. 62(11):919–923.
27.Pastorello EA, Farioli L, Losappio LM, Morici N, Di Biase M, Nichelatti M et al: Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years. Clinical and molecular allergy: CMA.2015; 13(1):14.
28.Sun Y, Chien KL, Hsu HC, Su TC, Chen MF, Lee YT: Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study. Circulation journal: official journal of the Japanese Circulation Society.2009; 73(8):1423–1430.
29.Martin-Herrero F, Martin-Moreiras J, Pabon P, Sanchez PL, Morinigo-Munoz JL, Jimenez-Candil J et al: Homocysteine and outcome in young patients with acute coronary syndromes. International journal of cardiology.2007; 118(2):183–188.